Postmenopausal Osteoporosis
Osteoporosis is a common metabolic bone disorder characterised by reduced bone strength and an increased risk of fractures. In postmenopausal women, declining oestrogen levels can accelerate bone loss, particularly when additional risk factors such as early menopause, inadequate calcium intake and limited physical activity are present.
Vertebral fractures may occur with minimal or no significant trauma and can present with back pain, height loss or progressive changes in posture. Early assessment and appropriate management can help reduce the risk of further fractures.
Patient Information
- Age/Sex: 62-year-old female
- Occupation: Homemaker
- Height: 154 cm
- Weight: 56 kg
- BMI: 23.6 kg/m²
- Menopause: At 47 years
- Chief Complaint: Back pain for 8 months and recent difficulty standing for prolonged periods
Clinical History
The patient reported gradual onset of mid- to lower-back pain without significant trauma. She had noticed a reduction in height of approximately 4 cm over the previous 5 years.
There was no history of fever, weight loss, neurological weakness or malignancy.
Identified Risk Factors
The following risk factors for osteoporosis and fracture were identified:
- Postmenopausal status
- Early menopause
- Low calcium intake
- Minimal weight-bearing exercise
- Limited sunlight exposure
- Maternal history of hip fracture at 75 years
- No smoking or alcohol use
Clinical Examination
On examination, the patient’s vital signs were stable.
The following findings were noted:
- Height: 154 cm
- Mild thoracic kyphosis
- Paravertebral tenderness
- No neurological deficit
- Normal gait
- No obvious peripheral fracture
The combination of back pain, height loss and thoracic kyphosis raised clinical suspicion of a vertebral compression fracture.
Diagnostic Assessment
Laboratory Investigations
Investigation | Result |
Haemoglobin | 12.4 g/dL |
Serum calcium | 9.2 mg/dL |
Serum phosphate | 3.5 mg/dL |
ALP | Normal |
Creatinine | 0.8 mg/dL |
25-OH Vitamin D | 18 ng/mL |
TSH | Normal |
PTH | Normal |
Bone Density and Imaging
Investigation | Result |
DXA lumbar spine T-score | −2.8 |
DXA total hip T-score | −2.5 |
Vertebral X-ray | Mild L1 compression deformity |
The DXA findings were consistent with osteoporosis, with T-scores of ≤ −2.5 at the lumbar spine and total hip. The vertebral X-ray demonstrated a mild L1 compression deformity.
Diagnosis
Postmenopausal osteoporosis with vertebral compression fracture and vitamin D insufficiency.
The diagnosis was supported by the patient’s postmenopausal status, low bone mineral density and evidence of vertebral compression.
Management Plan
Management focused on reducing fracture risk, improving bone health and addressing modifiable risk factors.
Lifestyle Management
The patient was counselled regarding:
- Adequate dietary calcium intake
- Vitamin D supplementation when indicated
- Regular weight-bearing and resistance exercise
- Balance training to reduce the risk of falls
- Avoidance of smoking and excessive alcohol
- Fall-risk assessment and home safety measures
Pharmacological Treatment
As the patient had osteoporosis with a vertebral compression fracture, pharmacological treatment was indicated.
Potential treatment options included:
- Oral bisphosphonates such as alendronate or risedronate
- Intravenous zoledronic acid
- Denosumab
- Anabolic therapy such as teriparatide or abaloparatide in selected patients at very high fracture risk
Treatment should be individualised according to fracture risk, renal function, contraindications, adherence and applicable local guidelines.
Follow-Up
The patient was advised to continue regular follow-up to monitor treatment response and fracture risk.
Follow-up included:
- Monitoring treatment adherence and adverse effects
- Correcting vitamin D deficiency and ensuring adequate calcium intake
- Periodic reassessment of fracture risk
- Repeat DXA after an appropriate treatment interval, commonly around 2 to 3 years depending on clinical circumstances
Clinical Learning Points
- Osteoporosis may remain clinically silent until a fragility fracture occurs.
- Height loss and new kyphosis should prompt evaluation for vertebral fractures.
- DXA is the standard test for diagnosing osteoporosis.
- A history of fragility fracture can indicate high or very high fracture risk even when the BMD T-score is not ≤ −2.5.
- Effective management requires both fracture-prevention medication and lifestyle and fall-prevention measures.
Discussion
This case highlights the importance of evaluating postmenopausal women who develop persistent back pain, height loss or postural changes. The patient’s early menopause, low calcium intake, limited weight-bearing exercise and family history represented additional risk factors for bone loss and fracture.
DXA confirmed osteoporosis at both the lumbar spine and total hip, while vertebral imaging identified an L1 compression deformity. These findings supported the need for pharmacological fracture prevention alongside calcium and vitamin D optimisation, exercise and fall-risk reduction.
Conclusion
Postmenopausal osteoporosis can progress silently and may first become apparent through a vertebral compression fracture. Recognising clinical risk factors, investigating unexplained height loss and back pain, and assessing bone mineral density can support early diagnosis and appropriate treatment.
For professional medical guidance, osteoporosis assessment or personalised bone-health care, please contact us to connect with the healthcare team.
Note: This case study is for illustrative and educational purposes only and should not replace professional medical advice. If you have persistent back pain, height loss or concerns about osteoporosis, please consult a qualified healthcare provider.
